PPARG and pancreatic neoplasm: PPAR-γ ligands inhibit the cellular proliferation of pancreatic cancer, a process comparable with the terminal differentiation induced by cessation of cell proliferation and the accumulation of cells in the G1 phase of the cell cycle (20).